Medtronic Board Appoints Greg Lewis as New Director | Effective June 26, 2023

Medtronic announced today that its Board of Directors appointed Greg Lewis, Senior Vice President and Chief Financial Officer at Honeywell, to the Board. Lewis will serve on the Audit Committee and the Finance and Financial Risk Committee, effective June 26, 2023.

“We are thrilled to have Greg Lewis join our Board. His background in financial leadership across multiple industries will be a strong asset as¬†Medtronic pushes forward a comprehensive transformation that will set us up to deliver on durable growth,” said Geoff Martha, Chairman and CEO of Medtronic.

“I’m honored to join the Medtronic Board of Directors. I believe in the company’s mission to alleviate pain, restore health and extend life,” Lewis said. “I’m excited to bring my experience to bear as they transform the company and move this mission forward.”

Lewis joined Honeywell in 2006 and has held a variety of financial leadership roles across the company, including Vice President of Corporate Finance and CFO of Honeywell’s Automation and Control Solutions (ACS) segment. Lewis started his career at Kraft Foods and went on to roles at Tyco International and the Stanley Works. He received his MBA from Fordham University and a bachelor’s degree in finance from the University of Connecticut.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy